Viral Vector News and Research

RSS
Viral Vector is a type of virus used in cancer therapy. The virus is changed in the laboratory and cannot cause disease. Viral vectors may produce tumor antigens (proteins found on a tumor cell) to stimulate an antitumor immune response in the body. Viral vectors may also be used to carry genes that can change cancer cells back to normal cells.
Genethon announces dosing of first patient at pediatric clinical trial platform for neuromuscular diseases

Genethon announces dosing of first patient at pediatric clinical trial platform for neuromuscular diseases

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

Researchers evaluate new drug for spinal muscular atrophy in a broader spectrum of patients

Researchers evaluate new drug for spinal muscular atrophy in a broader spectrum of patients

Fight for Sight funds research to explore gene editing as treatment for inherited retinal diseases

Fight for Sight funds research to explore gene editing as treatment for inherited retinal diseases

mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

Single Sputnik V vaccine dose elicits robust immune response in previously infected individuals

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

Dual-antigen COVID-19 vaccine elicits humoral and cellular immune responses in mice

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

Study explores how CAR T immunotherapy could be used to treat solid tumors

Study explores how CAR T immunotherapy could be used to treat solid tumors

New study provides comparative analysis of twelve COVID-19 vaccines

New study provides comparative analysis of twelve COVID-19 vaccines

Beneficial effects of gene therapy can be seen in SCID-X1 patients decades after treatment

Beneficial effects of gene therapy can be seen in SCID-X1 patients decades after treatment

New approach could treat infertility caused by abnormal GnRH secretion

New approach could treat infertility caused by abnormal GnRH secretion

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

Novel SARS-CoV-2 spike vaccine candidate produces strong neutralizing response in vivo

Novel SARS-CoV-2 spike vaccine candidate produces strong neutralizing response in vivo

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2?

Could measles virus vectors be used for a new COVID-19 vaccine?

Could measles virus vectors be used for a new COVID-19 vaccine?

Viruses can use freshwater sources as vector for transmission, study suggests

Viruses can use freshwater sources as vector for transmission, study suggests